The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Lupin receives US FDA tentative approval for raltegravir tablets, USP: Our Bureau, Mumbai Friday, November 8, 2024, 17:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...

Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Oct 31 (Reuters) - Merck & Co (MRK.N), opens new tab said ... disrupts business and scuttles hospital deals with international pharmaceutical companies. The company expects Gardasil shipments ...

Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

Under this partnership, Teijin and Hilleman Laboratories will leverage their individual strengths to foster greater synergy ...

and has held senior level positions at Penwest Pharmaceuticals, Eurand International BV, Abbott Laboratories and Merck, Sharp and Dohme. His guidance will reinforce Morphocell’s strategic direction as ...

We recently compiled a list of the 8 Best Stocks to Buy for High Returns in 2024. In this article, we are going to take a ...

TROY, Mich., Oct. 25, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Merck & Co. (NYSE: MRK) as its "Stock to Study" and ...